Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(33%)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_3
2
33%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
2(40.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Terminated(1)
Other(2)

Detailed Status

Recruiting2
unknown2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (40.0%)
N/A3 (60.0%)

Trials by Status

terminated117%
recruiting233%
not_yet_recruiting117%
unknown233%

Recent Activity

2 active trials
Showing 5 of 6
recruiting

Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.

NCT02956031
not_yet_recruitingnot_applicable

Large Loop Excision of the Transformation Zone During Follicular Vs. Luteal Phase of the Menstrual Cycle (LLETZ-MC)

NCT05391243
recruitingnot_applicable

Comparison of LLETZ Versus LEEP for the Treatment of Cervical Dysplasia

NCT04772937
unknownnot_applicable

Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ

NCT04859361
terminatedphase_3

Imiquimod Treatment of CIN Lesions

NCT02329171
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT02956031

Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.

Recruiting
NCT05391243Not Applicable

Large Loop Excision of the Transformation Zone During Follicular Vs. Luteal Phase of the Menstrual Cycle (LLETZ-MC)

Not Yet Recruiting
NCT04772937Not Applicable

Comparison of LLETZ Versus LEEP for the Treatment of Cervical Dysplasia

Recruiting
NCT04859361Not Applicable

Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ

Unknown
NCT02329171Phase 3

Imiquimod Treatment of CIN Lesions

Terminated
NCT02669459Phase 3

Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol

Unknown

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6